New protocol/trial design, if approved and adopted would see the needed recruitment drop to 130 and less strict inclusion criteria. Not going to help the price reaction today, but if adopted should significantly aid recruitment.
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-10
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 532 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8695 | 1 |
View Market Depth
| Last trade - 16.12pm 12/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable